Arrowstreet Capital Limited Partnership Purchases 58,002 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

Arrowstreet Capital Limited Partnership lifted its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 36.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 216,069 shares of the company’s stock after buying an additional 58,002 shares during the quarter. Arrowstreet Capital Limited Partnership’s […]

Leave a Reply

Your email address will not be published.

Previous post China says it will ‘fight to the end’ after Trump threatens to impose still more tariffs
Next post Alliancebernstein L.P. Sells 55,443 Shares of Winnebago Industries, Inc. (NYSE:WGO)